Home » Topics » BioWorld Science

BioWorld Science
RSS

Amgen patents short transient receptor potential channel 6 antagonists

May 13, 2019

New broad spectrum antivirals discovered at FORGE Life Science

May 13, 2019

Polyphor temporarily halts enrollment in phase III studies of murepavadin

May 13, 2019

Gene editing restores skin functionality in blistering disease

May 13, 2019

SHR-1210 plus capecitabine and oxaliplatin shows promising safety and efficacy in GC/GEJ

May 13, 2019

Investigators present phase II data for CBT-001 for the treatment of pterygia

May 13, 2019

AAI 2019: T-cell therapy could be brought within reach of "virtually all" patients

May 13, 2019

LY-3154207 demonstrates linear plasma PK and promising safety in healthy volunteers

May 13, 2019

Merck & Co. discovers dual TBK1/IKBKE inhibitors

May 13, 2019

NIH initiates LATITUDE study to evaluate long-acting HIV medication

May 13, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 31, 2025
Novo Nordisk licenses Lexicon’s preclinical obesity drug in $1B deal
BioWorld Science
As companies continually search for next-generation obesity prospects, one of the leaders in the disease space, Novo Nordisk A/S, has obtained an exclusive...
Corcept looks to NDA following strong phase III ovarian cancer data
BioWorld
Relacorilant, a cortisol modulator from Corcept Therapeutics Inc., produced new and strong phase III results in treating platinum-resistant ovarian cancer. The...
Otsuka submits first BLA to FDA for sibeprenlimab in IgAN
BioWorld
Otsuka Pharmaceutical Development & Commercialization Inc. filed its BLA with the U.S. FDA for sibeprenlimab to treat immunoglobulin A nephropathy (IgAN). The...